Quarterly report [Sections 13 or 15(d)]

Segments (Tables)

v3.25.1
Segments (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Research and Development Expenses The following table summarizes our research and development expenses for the three months ended March 31, 2025 and 2024:
Three Months Ended March 31,
2025 2024
Nonclinical expenses $ 83  $ 152 
Clinical expenses 3,850  62 
CMC expenses 1,979  254 
Internal expenses:
Salaries, benefits and related costs 1,850  1,324 
Stock-based compensation expense 1,301  269 
Other 60  55 
$ 9,123  $ 2,116